Medicare prescription drug cost, prescriptions and prescribers, 2024
Medicare cost, 2024
$13.5M
+14.5% from 2023
Prescriptions
1,228
$11,017.84 per claim
Patients
110
97 prescribers
Total spending, 2024
$13.5M
$122,999.12 per patient
Medicare prescription drug plans paid $13.5M for Remodulin in 2024, for 1,228 prescriptions and refills to 110 patients (up 14.5% from 2023). The average cost per claim was $11,017.84.
Texas had the highest Medicare cost for Remodulin in 2024: $1.5M for 136 claims, followed by Arizona ($927K).
Vallerie V McLaughlin, cardiology in Ann Arbor, MI, had the highest Medicare cost for Remodulin in 2024: 12 claims costing $569K.
Remodulin is made by United Therapeutics Corporation (UTHR), listed in the Medicare spending data as United Therap.
All plans and makers
Where the prescribers practice, 2024
By Medicare drug cost
| Prescriber | Type | Claims | Patients | Cost |
|---|---|---|---|---|
| Vallerie V McLaughlin Ann Arbor, MI | Cardiology | 12 | Under 11 | $569K |
| Mary Whittenhall Attleboro, MA | Nurse Practitioner | 57 | Under 11 | $556K |
| Christina Migliore |
| Year | Prescribers | Claims | Patients | Cost |
|---|---|---|---|---|
| 2022 | 80 | 722 | 88 | $10.3M |
| 2023 | 88 | 1,148 | 95 | $11.8M |
| 2024 | 97 | 1,228 | 110 | $13.5M |
Amount reimbursed by state Medicaid programs, all states
More drugs: top Medicare drugs by cost and the Prescriptions tab.
Official US government data on Medicare prescription drug plans (Part D) and Medicaid drug use. Cost and spending are before the rebates drug makers pay. Prescribers with fewer than 11 claims of the drug are not published.
| Internal Medicine |
| 54 |
| Under 11 |
| $517K |
| Lillian M Hansen Tucson, AZ | Nurse Practitioner | 33 | Under 11 | $508K |
| Rodolfo A Estrada Anzueto San Antonio, TX | Pulmonary Disease | 13 | Under 11 | $465K |
| Jeffrey I Stewart Lebanon, NH | Pulmonary Disease | 43 | Under 11 | $403K |
| Leslie Spikes Kansas City, KS | Pulmonary Disease | 11 | Under 11 | $402K |
| Rahul G Argula Charleston, SC | Pulmonary Disease | 38 | Under 11 | $377K |
| William L Harvey Carmel, IN | Critical Care (Intensivists) | 15 | Under 11 | $357K |
| Phillip Joseph New Haven, CT | Pulmonary Disease | 43 | Under 11 | $326K |
| Dafne T Moretta Loma Linda, CA | Pulmonary Disease | 22 | Under 11 | $297K |
| Touraj Taghizadeh Middleburg Heights, OH | Cardiology | 11 | Under 11 | $296K |
| Anna K Dvorak Austin, TX | Pulmonary Disease | 53 | Under 11 | $290K |
| Jimmy S Smith Lexington, KY | Critical Care (Intensivists) | 22 | Under 11 | $287K |
| Mary Bartlett Mineola, NY | Nurse Practitioner | 11 | Under 11 | $286K |
| Ronald Zolty Omaha, NE | Advanced Heart Failure and Transplant Cardiology | 16 | Under 11 | $281K |
| Parth M Rali Philadelphia, PA | Pulmonary Disease | 11 | Under 11 | $260K |
| Oksana A Shlobin Falls Church, VA | Critical Care (Intensivists) | 14 | Under 11 | $260K |
| Catherine J Markin Portland, OR | Pulmonary Disease | 18 | Under 11 | $247K |
| Kerri A Smith Philadelphia, PA | Critical Care (Intensivists) | 19 | Under 11 | $247K |
| Michael Insel Tucson, AZ | Pulmonary Disease | 20 | Under 11 | $238K |
| Ernest A Haeusslein Austin, TX | Cardiology | 13 | Under 11 | $228K |
| Jeremy A Mazurek Philadelphia, PA | Advanced Heart Failure and Transplant Cardiology | 19 | Under 11 | $223K |
| Marjorie P George Denver, CO | Critical Care (Intensivists) | 12 | Under 11 | $216K |
| Mona Vashi Chicago, IL | Pulmonary Disease | 28 | Under 11 | $201K |
Spending by manufacturer as listed in the spending data
| Manufacturer | Claims | Spending |
|---|---|---|
| United Therap UTHR | 1,228 | $13.5M |